These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. A 24-week, randomized, controlled trial of adjunctive sibutramine versus topiramate in the treatment of weight gain in overweight or obese patients with bipolar disorders. McElroy SL; Frye MA; Altshuler LL; Suppes T; Hellemann G; Black D; Mintz J; Kupka R; Nolen W; Leverich GS; Denicoff KD; Post RM; Keck PE Bipolar Disord; 2007 Jun; 9(4):426-34. PubMed ID: 17547588 [TBL] [Abstract][Full Text] [Related]
14. Sibutramine-induced mania as the first manifestation of bipolar disorder. Waszkiewicz N; Zalewska-Szajda B; Szajda SD; Simonienko K; Zalewska A; Szulc A; Ładny JR; Zwierz K BMC Psychiatry; 2012 May; 12():43. PubMed ID: 22607132 [TBL] [Abstract][Full Text] [Related]
15. Controversy about the cardiovascular safety of sibutramine. Scheen AJ Drug Saf; 2010 Jul; 33(7):615-8. PubMed ID: 20553062 [No Abstract] [Full Text] [Related]
16. Sibutramine for obesity. Med Lett Drugs Ther; 1998 Mar; 40(1022):32. PubMed ID: 9529518 [No Abstract] [Full Text] [Related]